Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N’-bis(2-bromoethyl)diamidophosphate

EU orphan designation number: EU/3/13/1152   
Active ingredient: (1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N’-bis(2-bromoethyl)diamidophosphate
Indication: Treatment of pancreatic cancer
Sponsor: Chiltern International Limited
171 Bath Road, Slough, Berkshire SL1 4AA, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/07/2013 Orphan designation EMA/OD/037/13 (2013)4726 of 17/07/2013
20/06/2016 Transfer of orphan designation EMA/OD/037/13/T/01 (2016)3845 of 16/06/2016